2.A.1 Name of plan "owner" (should be faculty PI) | Nesrine | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2.A.2 CMU-Q email of plan owner | Email hidden; Javascript is required. | |||||||||||||||
2.A.3 Department of plan owner | Biological Sciences | |||||||||||||||
2.B Justification of on-site work | I have ongoing research using cell lines and experiments that require my physical presence in the lab. I will try my best to do these experiments in the lab and analyze the data remotely. | |||||||||||||||
2.C.1 Facility details and locations |
| |||||||||||||||
2.C.2 Personnel details |
| |||||||||||||||
2.C.3 Acknowledge that people listed above have been consulted |
| |||||||||||||||
2.D Pandemic Safety Officer |
| |||||||||||||||
2.E.1 Short descriptoin of project(s) and type(s) of work | The project will involve growing cells in 3D cultures and optimizing techniques for flow cytometry and immunofluorescence staining, in addition to performing migration assays with dye tracers. These assays will be optimized by the faculty alone in the fall semester in anticipation/ preparation for students in my lab currently interested in working on their Honor thesis for the spring semester. | |||||||||||||||
2.E.2 Does your work involve human subjects? | No | |||||||||||||||
2.E.3 If not requesting ongoing access, list date ranges for which you are requesting access | ongoing access | |||||||||||||||
2.G.1.a Describe any scheduling tools you will use to control access to particular rooms and appratus? | Our department had created a shared research activity planner that was et up by IT to avoid crowding and overlapping in lab spaces. | |||||||||||||||
2.G.1.b If you intend to use pre-defined rotations or shifts, attach (at end) or provide below an example schedule | see attached example from a shared calendar indicated people rotations and different log in times into shared lab spaces | |||||||||||||||
2.G.1.c Are there any circumstances where personnel CANNOT maintain physical distancing for short periods of time? | No | |||||||||||||||
2.G.2 Anyone who is sick must stay home |
| |||||||||||||||
2.G.3 Face masks |
| |||||||||||||||
2.G.4 Individual hygiene & hand-washing |
| |||||||||||||||
2.G.5 Facility entrance/exit logging processes | All users of research space will enter their planned occupancy in a shared calendar, they will revise the calendar if their plans change. The department has discussed with facilities using the normal door card scanners to generate an independent log of room access. | |||||||||||||||
3 Ramp-down and temporary suspension of work plans | Ongoing cells will be frozen and stored at -80 freezers. any ongoing experiment will be stopped and cells killed by bleach. Ramp down time < 24 hours for all of these activities. See additional information in the uploaded document in 6b. | |||||||||||||||
4 Regular reporting details |
| |||||||||||||||
5 Acknowledgement of positive COVID-19 diagnosis response protocols and temporary work suspension |
| |||||||||||||||
6.b Attachments |